Antibiotics Clinical Trial
Official title:
Comparison of the Pharmacokinetic and the Safety of Daptomycin Administered Subcutaneously Compared to the Intravenous Route : a Cross-over Study
Background: Multidrug-resistant bacteria are a major public health problem worldwide, notably due to excess mortality and an increase in the length of hospital stay. Antibiotics that can be used to treat these infections are limited. Daptomycin is one of the most widely used antibiotics for the treatment of infections with gram-positive bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA). However, it is only administered intravenously (IV). It is therefore interesting to find new routes of administration in order to widen the possibilities of using daptomycin, especially in people who have difficulties with the venous approach. Methods/design: In a randomized, single blinded, crossover, noninferiority study in the CHU of Caen, the investigators aim to demonstrate the pharmacokinetic bioequivalence between the subcutaneous and the intravenous route of daptomycin in healthy volunteers. They will conclude the bioequivalence if the confidence interval of the area under the curve obtained is entirely within the interval [80% - 125%]. Discussion: This clinical trial could, if bioequivalence is demonstrated, lead to the completion of a clinical trial in infected patients in order to assess the efficacy and safety of daptomycin by the subcutaneous route.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05337566 -
Does Additional Use of Preoperative Azithromycin Decrease Posthysterectomy Infections
|
N/A | |
Completed |
NCT02874872 -
Building a Novel Antibiotic Stewardship Intervention for Nursing Homes
|
N/A | |
Completed |
NCT03909698 -
Antibiotic Dosing in Patients on Intermittent Hemodialysis
|
||
Not yet recruiting |
NCT06402292 -
Surgical Treatment of Osteoarticular Infections Using Bioactive Bone Substitute
|
N/A | |
Recruiting |
NCT04669717 -
Antibiotics as Adjuncts to Periodontal Therapy:Pharmacokinetic Considerations and Dosing Strategies
|
Phase 4 | |
Completed |
NCT03464279 -
Use of a Behavioral Economic Intervention to Reduce Antibiotic Prescription for Upper Respiratory Infections
|
N/A | |
Completed |
NCT03131063 -
Pharmacokinetic Study of Antibiotics in Patients Assisted by Extracorporeal Membrane Oxygenation (PHARMECMO)
|
N/A | |
Completed |
NCT03335137 -
Determining Drug Levels of Beta-lactam Antibiotics in Severe Burned Patients
|
N/A | |
Recruiting |
NCT05553743 -
Researchers at UC San Diego Are Learning About the Benefits of Human Milk and How it Influences Infant and Child Health
|
||
Recruiting |
NCT05519761 -
A Retrospective, Observational, Multicenter Study to Evaluate the Safety and Performance of POLYSITE® and SEESITE® Implantable Ports
|
||
Completed |
NCT02927743 -
Effect of Evidence-based Reminders on Use of Antibiotics
|
N/A | |
Not yet recruiting |
NCT03178292 -
Conventional Antibiotic Prophylaxis Versus Add-On 5 Days Levofloxacin Before Percutaneous Nephrolithotomy
|
N/A | |
Completed |
NCT02118402 -
Iron and Prebiotics Fortification in Kenyan Infants
|
N/A | |
Completed |
NCT00791505 -
Antibiotic/COPD in Acute Exacerbation of Chronic Obstructive Pulmonary Disease (COPD) Requiring Mechanical Ventilation
|
Phase 3 | |
Not yet recruiting |
NCT04966390 -
Standardized Clinical Application of Antibacterial/Anitifungal Drugs
|
||
Recruiting |
NCT05052619 -
Preventive Therapy of Postoperative Intra-abdominal Infection Based on Serum Lactate Changes
|
N/A | |
Recruiting |
NCT03014687 -
Prophylactic Oral Antibiotics on Sinonasal Outcomes Following Endoscopic Transsphenoidal Surgery for Pituitary Lesions
|
Phase 4 | |
Withdrawn |
NCT01463943 -
Non-Inferiority Trial Comparing Eurofarma's Experimental Product Saccharomyces Boulardii Versus Floratil® in the Prevention of Antibiotic-Associated Diarrhea
|
Phase 3 | |
Completed |
NCT04493008 -
Antibiotic Usage and Resistance; Knowledge and Practices Before and After Educational Sessions
|
N/A | |
Recruiting |
NCT03361267 -
Comparison of Bismuth Containing Quadruple Therapy and Based Tailored Therapy for H. Pylori Infection
|
N/A |